INTRODUCTION
============

Lysosomes are membranous cell organelles that are involved in endocytosis, exocytosis, and intracellular trafficking of vesicles ([@b4-molce-39-7-566]) and autophagy ([@b36-molce-39-7-566]). These organelles play a major metabolic role in the intracellular digestion of macromolecules such as carbohydrates, proteins, lipids, and nucleic acids. A spectrum of 50 hydrolytic enzymes is involved in the lysosomal catabolic process. Abnormal regulation of this pathway appears to be linked to lysosomal storage diseases such as Danon disease, Tay-Sachs disease, and Gaucher disease ([@b15-molce-39-7-566]; [@b19-molce-39-7-566]).

In response to bacterial infection, cellular pattern recognition receptors, such as Toll-like receptors (TLRs) and Nod-like receptors (NLRs), are known to be activated to initiate the autophagic (or xenophagic) process ([@b39-molce-39-7-566]). Lysosomes play a key role in innate immune defense by fusing with and degrading pathogens contained in autophagic vesicles directly, or fusing with the pathogen-containing vesicles ([@b27-molce-39-7-566]; [@b28-molce-39-7-566]). These processes generally result in the destruction of the invasive bacteria, although some bacteria, including *Salmonella* Typhimurium and *Mycobacterium tuberculosis*, can block the maturation of phagosomes into degradative organelles called phagolysosomes ([@b12-molce-39-7-566]; [@b24-molce-39-7-566]).

*Salmonella enterica* serovar Typhimurium (*S.* Typhimurium) is a gram negative bacteria that can infect and proliferate inside the intestinal epithelium and macrophages, triggering gastrointestinal disease ([@b14-molce-39-7-566]; [@b20-molce-39-7-566]). The process of *Salmonella* infection is known to be controlled by *Salmonella* Pathogenicity Island-1 (SPI-1), which encodes a set of the bacterial proteins, known as the type III secretion system (TTSS or T3SS). SPI-1 is required for the invasion of non-phagocytic cells (Schmidt and Hensel, 2014). Intracellular proliferation proceeds inside the *Salmonella* containing vacuole (SCV) or the Sif (*Salmonella*-induced filament) and requires *Salmonella* Pathogenicity Island-2 (SPI-2) for protection against the functioning of intracellular effectors such as phagocyte oxidase ([@b40-molce-39-7-566]) and inducible nitric oxide synthase ([@b13-molce-39-7-566]; Schmidt and Hensel, 2014).

LAMP-1 and LAMP-2 are major lysosomal membrane proteins that account for about half of the total lysosomal membrane proteins. These glycoproteins are responsible for maintaining lysosomal integrity, pH, and catabolism ([@b2-molce-39-7-566]; [@b18-molce-39-7-566]). Aberrant localization or expression of LAMP-2 has been implicated in human disease. Expression of LAMP-2 on the cell surface has been implicated in *cancer cell survival and metastasis* ([@b1-molce-39-7-566]; [@b37-molce-39-7-566])*.* Moreover, LAMP-2 deficiency is associated with Danon disease, a lysosomal storage disease, characterized by *vacuolar cardiomyopathy and myopathy* ([@b34-molce-39-7-566]).

Compared to LAMP-1 and LAMP-2, LAMP-3 is poorly understood. LAMP-3 exhibits 30% and 28% amino acid sequence identity to LAMP-1 and LAMP-2 respectively. LAMP-3 carries numerous potential glycosylation sites in comparison to those of LAMP-1 or LAMP-2 ([@b16-molce-39-7-566]; [@b42-molce-39-7-566]). In contrast to the constitutive expression of LAMP-1 and LAMP-2 in many cell types, LAMP-3 expression is regulated temporally and spatially, or is induced by hypoxic conditions. Overexpression of LAMP-3 is known to be associated with cancer metastasis ([@b29-molce-39-7-566]; [@b30-molce-39-7-566]; [@b32-molce-39-7-566]). Recently, LAMP-3 was reported to be associated with modulation of autophagy and autophagy-mediated drug sensitivity ([@b17-molce-39-7-566]; [@b33-molce-39-7-566]). Compared to LAMP-1 and LAMP-2, LAMP-3 remains poorly understood for its role in the bacterial infection process and we investigated whether LAMP-3 expression plays a role in the *Salmonella* infection cycle.

MATERIALS AND METHODS
=====================

Reagents
--------

Antibodies against phospho-p38 MAPK, phospho-NF-κB p65 were purchased from Cell Signaling (USA). Antibodies against p38MAPK, Anti-NF-κB, LAMP-1, LAMP-2 and LAMP-3 were purchased from Santa Cruz (USA). Anti-GAPDH antibody was purchased from Ab Frontier (Korea). RNA Blood Mini kit (QIAGEN, USA) and cDNA synthesis kit were purchased respectively from QIAGEN (Netherlands) and Invitrogen (USA). LPS and PEI transfection reagents were purchased from Sigma-Aldrich, USA. LAMP-3 shRNA and scrambled shRNA constructs (29mer each) in pRS plasmid were purchased from Origene (USA).

Chemical Inhibitors of NF-κB (PDTC) and JNK II were purchased from Calbiochem (USA). ERK inhibitor (FR180204) and p38 inhibitor (AMG548) were purchased from Tocris Bioscience (UK).

*Salmonella typhimurium* 1406S(EGFP) was provided by Dr. Choy HE (Chonnam Natl' Univ., Korea). Overnight culture of the bacteria was inoculated in fresh LB broth containing 100 ug/ml Ampicillin at a ratio of 1/33 dilution and cultured for 4 h before harvest and use for the cell infection, confocal assay and cell proliferation assay.

Cell culture
------------

HeLa cells were cultured in DMEM media supplemented with 10% FBS and penicillin/streptomycin (P/S) antibiotics. THP-1 cells, a pro-monocytic cell line, were culture in RPMI 1640 (Life Technologies, USA) containing 10% FBS (WellGene, Korea), P/S antibiotics (Life Technologies, USA) and 0.05mM mercaptoethanol (Sigma-Aldich, USA). All cell cultures were maintained at 5% CO~2~ and 37°C.

RNA isolation and RT-PCR
------------------------

After treatment with 1ug/ml LPS or Salmonella bacteria, total RNAs were isolated from THP-1 cells using the RNA Blood Mini kit according to the manufacturer's instructions (QIAGEN, USA). cDNA synthesis and RT-PCR analysis were performed simultaneously in a single tube using 10ng/ml of total RNA according to the manufacture's instruction (AccuPower® RocketScript^TM^ RT Premix (Bioneer, Korea); cDNA was synthesized using the primers listed below at 42°C for 40 min., followed by pre-denaturation at 95°C for 5min., and 35 cycles (95°C/30 s → 54°C /30 s → 72°C /30 s) of PCR reaction before the final extension (72°C/10 min.) step. The primers used in this study were designed according to "Primer 3 program (Whithead Institute, USA)" and are listed in Table 1.

Stable LAMP-3 knock-down cell line
----------------------------------

Hela cells were transfected by PEI transfection reagent with two LAMP-3 shRNA plasmids containing the following oligonucleotides (5′-ACTGGAACCAGTTCATCAACCGTCAGCC-3′ and 5′-GTGGATGAGT GCTCGTCTGACTACACAAT-3′). Two days later, puromycin selection was followed at 1 ug/ml concentration and the emerging colonies were checked for the expression level of LAMP-3 knock-down by western blotting with anti LAMP-3 antibody.

Intracellular survival assay of *Salmonella typhimurium*
--------------------------------------------------------

HeLa cells, at about 60% confluency, were infected with salmonella (eGFP) for 30 min. and treated with gentamycin (50 ug/ml) for 30 min. before PBS washing 3 times. Subsequently, the infected HeLa cells were washed 3 times with PBS buffer and lyzed with lysis buffer (0.1% Triton X-100, 0.1% SDS, PBS). The lysates were serially diluted in PBS and plated on LB plate containing ampicillin (100 ug/ml). After overnight, the number of bacteria colonies was counted for CFU.

N-SIM super resolution microscopy
---------------------------------

HeLa cells (1 × 10^6^/well) were cultured in DMEM growth media overnight on coverglass in 35 mm dish (NUNC) before infection with Salmonella (eGFP) at about 1:40 MOI. To remove any extracellular bacteria, gentamicin was added 30 min later at the final concentration of 50 ug/ml and after an hour, the media was removed and replaced with fresh DMEM growth media for the indicated time. After washing with PBS 3 times, the HeLa cells were fixed with 4% paraformaldehyde for 10 min, permeabilized with 0.1% Triton X-100 for 10 min. After PBS washing, the cells were blocked with 10% FBS in PBS for 30 min. and reacted with primary LAMP-2 and LAMP-3 antibodies for 3 h and after PBS washing, incubated with secondary antibody (Alexa-594 or Alexa-633) for 2 h and washed with PBS buffer before mounting on slide glass for N-SIM microscope analysis with NIS-Elements Viewer.

RESULTS
=======

LPS and *Salmonella* infection increases *LAMP-3* expression
------------------------------------------------------------

To identify lipopolysaccharide (LPS) responsive genes, we used the Illumina HumanHT-12 v4 Expression BeadChip Kit. We identified *LAMP-3* as a gene that is upregulated in response to LPS. Then, we characterized the regulation of LAMP-3 expression and its effects on the intracellular proliferation of *Salmonella* Typhimurium*.*

In order to confirm that LPS induces *LAMP-3* gene expression, we treated THP-1 cells with 1 μg/ml of LPS for 1, 4, or 8 h, isolated total RNA, and performed RT-PCR analysis. *LAMP-3* was up-regulated 2-fold following 4--8 h of LPS stimulation ([Fig. 1A](#f1-molce-39-7-566){ref-type="fig"}). On the other hand, *LAMP-1* and *LAMP-2* expression were unchanged despite LPS stimulation. These results were confirmed further by western blot analysis; *LAMP-3* expression increased as early as 1 h after LPS stimulation and reached the maximum expression level 8 h after LPS stimulation from 1.2-fold to 1.5-fold repectively. LAMP-1 and LAMP-2 expression were similar to the unstimulated control ([Fig. 1B](#f1-molce-39-7-566){ref-type="fig"}). To determine whether the difference in LAMP gene expression and protein production was LPS-specific, we tested expression levels in response to *Salmonella* bacteria. *Salmonella* caused increased expression of LAMP-3 and LAMP-2 in both RT-PCR and Western blot analysis, but LAMP-1 was unaffected ([Figs. 1C and 1D](#f1-molce-39-7-566){ref-type="fig"}). Several bands of LAMP-3, at approximately 70 kDa in size, appeared depending on the time after the stimulation and may be related to differences in the glycosylation process. We obtained similar results when we tested LAMP expression in the Salmonella infected HeLa cells; LAMP-3 was the most upregulated among the three LAMPs in both RT-PCR and western blot analyses ([Figs. 1E and 1F](#f1-molce-39-7-566){ref-type="fig"}).

Upregulation of LAMP-3 is closely associated with the activation of the NF-κB and p38 MAPK signaling pathways
-------------------------------------------------------------------------------------------------------------

Given the central role of TLR4 in the LPS-mediated signaling pathway including NF-κB, ERK, JNK and p38 ([@b22-molce-39-7-566]), we investigated which of these signaling components might control the LAMP-3 expression. We treated THP-1 cells for 30 min with the following chemical inhibitors; ammonium pyrrolidinedithiocarbamate (PDTC: (NF-κB inhibitor, 20 μg/ml)), FR180204 (ERK inhibitor, μM), 420119 (JNK II inhibitor, 40 μM), and AMG548 (p38 inhibitor, 20 μM). Then, cells were stimulated with 1 μg/ml of LPS for 4 hrs and RNA or protein was isolated from the cells. As expected, RT-PCR analysis indicated that LPS stimulation caused a 2-fold increase in *LAMP-3* transcript levels (PBS+LPS vs. PBS). However, inhibition of NF-κB and p38 MAPK caused reduced levels of *LAMP-3* transcripts. Using phospho-specific antibodies, we examined whether NF-κB and p38 were phosphorylated in response to LPS stimulation ([Figs. 2A and 2B](#f2-molce-39-7-566){ref-type="fig"}). LPS stimulation caused increased phosphorylation of p38, but not NF-κB ([Figs. 2C and 2D](#f2-molce-39-7-566){ref-type="fig"}). In the presence of each inhibitor, phosphorylation was decreased dramatically, but the total amount of protein was unchanged. When THP-1 cells were treated with chemical inhibitors followed by *Salmonella* infection for 4 h, LAMP-3 protein levels were reduced in the following order: NF-κB (PDTC), p38 MAPK, JNK, and ERK ([Figs. 2E and 2F](#f2-molce-39-7-566){ref-type="fig"}). In the PBS control, LAMP-3 protein levels were increased. Tubulin was used as a protein loading control.

LAMP-3 colocalizes with *Salmonella* Typhimurium
------------------------------------------------

The N-SIM super-resolution microscope was used to investigate the colocalization of LAMP-3 with LAMP-2 and *Salmonella* Typhimurium (eGFP) in HeLa cells. In uninfected control cells, LAMP-3 (blue) was apparent as dots that were evenly distributed at the cell periphery, while LAMP-2 was observed at the cell periphery as larger aggregates ([Fig. 3, top row](#f3-molce-39-7-566){ref-type="fig"}). Five hours after infection, a portion of the LAMP-3 colocalized with *Salmonella* bacteria (green) in the cytosol, which was observed as light blue, whereas the remainder of the LAMP-3 signal appeared as dots in the cytosol. On the other hand, some LAMP-2 protein surrounded the *Salmonella* and also LAMP-3, while the remainder of the LAMP-2 signal appeared as aggregates. It is interesting to note that LAMP-3 was almost absent in the plasma membrane area following *Salmonella* infection ([Fig 3, middle row](#f3-molce-39-7-566){ref-type="fig"}). At 8 h post-infection, LAMP-3 colocalized with *Salmonella* as seen at 5 hrs post-infection, but LAMP-2 protein localized distinctly away from *Salmonella* ([Fig 3, bottom row](#f3-molce-39-7-566){ref-type="fig"}).

LAMP-3 knockdown interferes with the intracellular proliferation of *Salmonella* Typhimurium
--------------------------------------------------------------------------------------------

To investigate the relationship between LAMP-3 expression and intracellular proliferation of *Salmonella*, a stable HeLa cell line was transfected with a cocktail of two shRNA plasmids that knock down *LAMP-3*. Compared to the control cells transfected with a scrambled shRNA plasmid, LAMP-3 protein expression was decreased in *LAMP-3* knockdown cells by 40% ([Figs. 4A and 4B](#f4-molce-39-7-566){ref-type="fig"}). Next, cells were infected with *Salmonella* for 2, 6, and 12 h. Cells were lysed to recover live bacteria that were cultured on bacterial growth media. After culturing overnight, the number of bacterial colonies from *LAMP-3* knockdown cells were counted and compared to those recovered from control cells (scrambled shRNA). Knockdown of LAMP-3 decreased the number of *Salmonella* by 47%, 55%, and 54% at each time point respectively. These data suggest that LAMP-3 may contribute to the intracellular proliferation of *Salmonella*. Down-regulation of LAMP-2 yielded similar results by decreasing the numbers of recovered live bacteria ([Figs. 4D, 4E and 4F](#f4-molce-39-7-566){ref-type="fig"}).

DISCUSSION
==========

Pathogenic *Salmonella* isolates, like mycobacteria, have evolved to avoid intracellular targeting to lysosomes and subsequent killing by establishing intracellular niches such as SCVs and Sifs ([@b6-molce-39-7-566]; [@b41-molce-39-7-566]). About 20% of *Salmonella* are estimated to be outside of SCVs and SIFs or have damaged SCV membranes inside infected cells ([@b11-molce-39-7-566]).

For intracellular survival, *Salmonella* recruits LAMP-1 and LAMP-2 from the cell surface ([@b7-molce-39-7-566]) to the SCV, and later to Sifs with the help of the SPI-1 effector protein SpoI ([@b6-molce-39-7-566]). LAMP-2 appears to be more important than LAMP-1 in establishing and maintaining SCVs and Sifs. RNAi mediated silencing of *LAMP-2* results in a greater reduction in the number of *Salmonella* than silencing of *LAMP-1* ([@b35-molce-39-7-566]). Despite their abundance, it is not clear how LAMP-1 and LAMP-2 proteins play a role in the biogenesis and maintenance of SCVs and Sifs. From a screening of LPS responsive genes in THP-1 cells, we identified LAMP-3 as one of the target genes. The human LAMP-3 amino acid sequence was similar in size, but distinctively different from LAMP-1 and LAMP-2 (data not shown).

Although LAMP-3 expression is documented in many cell types including lung, dendritic, and cancer cells, as well as influenza virus-infected cells ([@b8-molce-39-7-566]; [@b9-molce-39-7-566]; [@b23-molce-39-7-566]; [@b25-molce-39-7-566]; [@b26-molce-39-7-566]; [@b16-molce-39-7-566]; [@b43-molce-39-7-566]), little is known about its expression in *Salmonella* infected cells. In contrast to constitutively and abundantly expressed LAMP-1 and LAMP-2 ([@b21-molce-39-7-566]), we show that LAMP-3 expression is inducible by both LPS and *Salmonella* at the transcriptional and translational levels in THP-1 and HeLa cells. *Salmonella* infection had a more profound effect on the expression levels of LAMPs than did LPS stimulation. LAMP-3 contains a greater number of potential glycosylation than seen in LAMP-1 and LAMP-2, and LAMP-3 protein migrated more frequently as multiple bands, as reported in previous studies ([@b17-molce-39-7-566]; [@b31-molce-39-7-566]).

LAMP-3 is also known to be a novel hypoxia-inducible gene under the control of the PERK/eIF2α/ATF4 arm of the unfolded protein response (UPR) and is independent of HIF-1α ([@b30-molce-39-7-566]; [@b31-molce-39-7-566]). In epithelial cells infected with either influenza A virus or *Pseudomonas aeruginosa*, increased LAMP-3 expression is observed endosomal or vacuolar compartments ([@b3-molce-39-7-566]; [@b43-molce-39-7-566]). As reported for the TLR4 signaling pathway in *Salmonella*-infected cells ([@b5-molce-39-7-566]), we found that the signaling route to LAMP-3 expression in THP-1 cells was dependent on NF-κB and p38 MAPK activity. In this study, NF-κB may be regulated by translocation of the p65 subunit into nucleus rather than by phosphorylation, whereas p38 MAPK is phosphorylated in response to LPS-mediated signaling. Similar to LPS stimulation, *Salmonella* infection appears to elicit similar signaling to activate NF-κB and p38 MAPK to a greater extent than the other MAPKs, although TLR2 is also known to be activated by *Salmonella* infection in mice ([@b5-molce-39-7-566]).

N-SIM super-resolution imaging data revealed that LAMP-3 localized at the periphery of HeLa cells before infection, but localized with *Salmonella* in the cytosol by 5--8 h after infection. Before infection, LAMP-3 partially colocalized at the cell surface with LAMP-2, but 5 h after infection, some LAMP-2 protein surrounded the *Salmonella,* as reported ([@b35-molce-39-7-566]). It is not clear why LAMP-2 and LAMP-3 colocalized before infection and exhibited distinct localization patterns after infection. Recruitment of LAMP-1 to SCVs is known to be controlled by SifA-mediated translocation. The absence of SifA protein in *Salmonella*-infected cells results in independent LAMP-1 localization away from SCV (Beuzón et al., 2000). In this regard, it remains to be investigated whether SifA may control LAMP-3 localization.

*LAMP-3* knockdown by specific RNAi expression in a stable cell line inhibited the intracellular proliferation of *Salmonella*, resulting in fewer recovered *Salmonella* bacterial colonies than seen in the case of control cells transfected with scrambled RNAi. *LAMP-2* knockdown also resulted in a similar suppression of intracellular proliferation of *Salmonella*. Given that the LAMP-3 localizes primarily at the cell surface before *Salmonella* infection and subsequently with intracellular *Salmonella*, there is a possibility that the downregulation of LAMP-3 and LAMP-2 may actually interfere with the *Salmonella* infection process at the cell surface, resulting in fewer numbers of infected bacteria per cell. The reduced number of *Salmonella* bacteria found at the 2-h time point, in *LAMP-3* or *LAMP-2* knockdown cells versus scrambled controls, may support this interpretation. Thus, LAMP-3 or LAMP-2 deficiency may impede the early *Salmonella* infection process at the cell surface through phagocytosis. In this regard, it will be useful to use a LAMP-3 knockout cell line to test this possibility.
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![LAMP-3 expression is controlled at the transcription and translation level by LPS and Salmonella in THP-1 and HeLa cells. THP-1 cells, at a density of 1.0 × 10^6^ cells/well, were treated with 1 ug/ml of LPS (A, B) or infected with *S. typhimurium* (C, D), or HeLa cells were infected with *S. typhimurium* (E, F). (A, C, and E) At each time point, total cellular RNA was extracted and subjected to RT-PCR with gene specific primers. Tubulin gene was used as an internal control. (B, D, and F) Protein levels of LAMP-1, LAMP-2 and LAMP-3 were examined by Western blotting with specific antibodies. GAPDH was included as a loading control.](molce-39-7-566f1){#f1-molce-39-7-566}

![Inhibition of NF-κB and p38 MAPK down-regulates the expression of LAMP-3. THP-1 cells were treated with each inhibitor at the indicated concentration (PDTC / NF-κB inhibitor, 20 ug/ml; FR180204 / ERK inhibitor, 50 uM; JNK II inhibitor / 420119 ; 40 uM, and AMG548 / p38 inhibitor, 20 uM) 30 min. prior to cell stimulation with LPS (1 ug/ml), PBS or DMSO for 4 h. (A, B) Extraction and analysis of mRNA were performed as described in "Materials and Methods". Levels of LAMP-3 transcripts were quantified by RT-PCR using gene specific primers and normalized against tubulin (an internal control). Results from a representative experiment are shown as mean ± S.E. (*n* = 3 of a single experiment). (C, D) Analysis of LAMP-3, NF-κB p65, and p38 MAPK protein expression was performed by western blotting with normal or phospho/activation-specific antibodies as indicated. (E) Experiments were done by adding inhibitors at indicated concentrations 30 min. prior to *Salmonella* infection for 4 h. LAMP-3 protein expression was examined by Western blotting with anti LAMP-3 antibody.](molce-39-7-566f2){#f2-molce-39-7-566}

![LAMP-3 co-localizes with *Salmonella typhimurium*. N-SIM super resolution microscope was used to investigate the co-localization of LAMP3 with LAMP2 and *Salmonella typhimurium* (eGFP) in Hela cells. HeLa cells were infected with PBS buffer (mock control) or the Salmonella bacteria for 5 or 8 h, and were processed as indicated in the materials and methods. After fixation, permeabilization and FBS blocking, the infected cells were reacted with primary LAMP-2 and LAMP-3 antibodies and with secondary antibodies (Alexa-594 or Alexa-633) before PBS washing and mounting on slide glass for N-SIM microscope analysis with NIS-Elements Viewer.](molce-39-7-566f3){#f3-molce-39-7-566}

![Interference of LAMP-3 expression inhibits intracellular proliferation of *Salmonella typhimurium*. (A) Stable control (Scrambled) or LAMP-3 knockdown HeLa cell line was checked for the level of down-regulation of LAMP-3 expression by western blotting using antibody against LAMP-3. GAPDH expression was checked as a loading control. (B) Intracellular proliferation of Salmonella was assayed according to the procedure in the materials and methods. The 2, 6 and 12 h after infection, the cells were lyzed with lysis buffer to isolate live bacteria in the LB agar plate containing 100 ug/ml of Ampicillin. After, overnight, the number of bacteria colonies was counted and compared to that of control cell line. Data are the average of three independent experiments. Error bars represent standard deviation. (C) LAMP-2 knockdown HeLa cell line was established and the level of LAMP-2 down-regulation was checked by Western blotting with anti-LAMP-2 antibody. (D) Intra cellular survival assay was performed with LAMP-2 K/D cell line and scrambled control cell line at 2 and 6 h after the Salmonella infection.](molce-39-7-566f4){#f4-molce-39-7-566}
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